Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas
Abstract Glioma, which accounts for more than 30% of primary central nervous system tumours, is characterised by symptoms such as headaches, epilepsy, and blurred vision. Glioblastoma multiforme is the most aggressive, malignant, and lethal brain tumour in adults. Even with progressive combination t...
Main Authors: | Qing Zhang, Wei Xiang, Dong-ye Yi, Bing-zhou Xue, Wan-wan Wen, Ahmed Abdelmaksoud, Nan-xiang Xiong, Xiao-bing Jiang, Hong-yang Zhao, Peng Fu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-08-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13287-018-0977-z |
Similar Items
-
CD90low glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells
by: Bing-zhou Xue, et al.
Published: (2021-07-01) -
Mesenchymal Stromal Cells
by: Stanisław Szala, et al.
Published: (2014-11-01) -
Mesenchymal stem cell-derived exosomes for the treatment of pulmonary diseases
by: X. Wang, et al.
Published: (2020-10-01) -
Freeze-Dried Secretome (Lyosecretome) from Mesenchymal Stem/Stromal Cells Promotes the Osteoinductive and Osteoconductive Properties of Titanium Cages
by: Elia Bari, et al.
Published: (2021-08-01) -
Mesenchymal Stem/Stromal Cell-Derived Exosomes for Immunomodulatory Therapeutics and Skin Regeneration
by: Dae Hyun Ha, et al.
Published: (2020-05-01)